A new company, IGL Pharma, Inc. has been formed to move CycloSam® forward through clinical trials. CycloSam® is a patented new bone-seeking radiopharmaceutical being developed for bone cancers, including the treatment of primary bone tumors, secondary bone metastases and for bone marrow ablation/transplant.